Hemodynamic effects of orally administered carvedilol in healthy conscious dogs

American Journal of Veterinary Research

Volumn 66, Issue 4, 2005, Pages 637-641

  Abbott, Jonathan A ^a   Broadstone, Richard V ^a   Ward, Daniel L ^a   Pyle, R Lee ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARVEDILOL; ISOPRENALINE; PHENYLEPHRINE; PLACEBO;

ANIMAL DISEASE; ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; CONGESTIVE HEART FAILURE; CONSCIOUSNESS; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; HEART INDEX; HEART RATE; HEART RIGHT ATRIUM PRESSURE; HEMODYNAMIC PARAMETERS; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; LUNG WEDGE PRESSURE; NONHUMAN; REST;

ADMINISTRATION, ORAL; ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; CARBAZOLES; DOGS; HEART FAILURE, CONGESTIVE; HEART RATE; HEMODYNAMIC PROCESSES; ISOPROTERENOL; PHENYLEPHRINE; PROPANOLAMINES; PULMONARY WEDGE PRESSURE; RANDOM ALLOCATION;

ANIMALIA; CANIS FAMILIARIS;

EID: 17544363934     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2005.66.637     Document Type: Article

References (19)

1. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT - CHF). Lancet 1999;353:2001-2007.
2. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 1996;334:1349-1355.
3. Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344:1651-1658.
4. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999;353:9-13.
5. Packer M, Colucci WS, Sackner-Bernstein JD, et al. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise. Circulation 1996;94:2793-2799.
6. Hjalmarson A, Goldstein S, Fagerberg B, et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA 2000;283:1295-1302.
7. Gilbert EM, Abraham WT, Olsen S, et al. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation 1996;94:2817-2825.
8. Kawada T, Ishibashi T, Nakazawa M, et al. Adrenoceptor-blocking activity and cardiohemodynamic effects of carvedilol in animals. J Cardiovasc Pharmacol 1990;16:147-153.
9. Sponer G, Bartsch W, Strein K, et al. Pharmacological profile of carvedilol as a beta-blocking agent with vasodilating and hypotensive properties. J Cardiovasc Pharmacol 1987;9:317-327.
10. Strein K, Sponer G, Muller-Beckmann B, et al. Pharmacological profile of carvedilol, a compound with beta-blocking and vasodilating properties. J Cardiovasc Pharmacol 1987;10(suppl 11):S33-S41.
11. Rush JE, Freeman LM, Hiler C, et al. Brown, D. J. Use of metoprolol in dogs with acquired cardiac disease. J Vet Cardiol 2002;4:23-28.
12. Sawangkoon S, Miyamoto M, Nakayama T, et al. Acute cardiovascular effects and pharmacokinetics of carvedilol in healthy dogs. Am J Vet Res 2000;61:57-60.
13. Uechi M, Sasaki T, Ueno K, et al. Cardiovascular and renal effects of carvedilol in dogs with heart failure. J Vet Med Sci 2002; 64:469-475.
14. Hoffman BB, Lefkowitz RJ. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Limbird LE, ed. Goodman & Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill Book Co, 1996;199-248.
15. Ishibashi T, Okuhira M, Hamaguchi M, et al. Effect of carvedilol on venous return: a mechanism of reduction in blood pressure. Jpn J Pharmacol 1991;55:186-189.
16. Kubo T, Azevedo ER, Newton GE, et al. Lack of evidence for peripheral alpha(1)-adrenoceptor blockade during long-term treatment of heart failure with carvedilol. J Am Coll Cardiol 2001; 38:1463-1469.
17. Cleland JG. Beta-blockers for heart failure: why, which, when, and where. Med Clin North Am 2003;87:339-371.
18. Papich MG. Saunders handbook of veterinary drugs. Philadelphia: WB Saunders Co, 2002;412-413.
19. Hancock AA, Brune ME, Witte DG, et al. Actions of A-131701, a novel, selective antagonist for alpha-1A compared with alpha-1B adrenoceptors on intraurethral and blood pressure responses in conscious dogs and a pharmacodynamic assessment of in vivo prostatic selectivity. J Pharmacol Exp Ther 1998;285:628-642.